<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Community Eye Health</journal-id><journal-id journal-id-type="iso-abbrev">Community Eye Health</journal-id><journal-id journal-id-type="publisher-id">Community Eye Health</journal-id><journal-title-group><journal-title>Community Eye Health</journal-title></journal-title-group><issn pub-type="ppub">0953-6833</issn><issn pub-type="epub">1993-7288</issn><publisher><publisher-name>International Centre for Eye Health</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29915463</article-id><article-id pub-id-type="pmc">5998387</article-id><article-id pub-id-type="publisher-id">jceh_31_101_017</article-id><article-categories><subj-group subj-group-type="heading"><subject>Histopathology</subject></subj-group></article-categories><title-group><article-title>Standard reporting of high-risk histopathology features in retinoblastoma</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Thaung</surname><given-names>Caroline</given-names></name><aff>Consultant Ophthalmic Pathologist: Moorfields Eye Hospital, Institute of Ophthalmology, London, UK. <italic>Teaching blog:</italic>
<bold><ext-link ext-link-type="uri" xlink:href="https://eyepathlondon.wordpress.com/">https://eyepathlondon.wordpress.com/</ext-link></bold></aff></contrib><contrib contrib-type="author"><name><surname>Karaa</surname><given-names>Esin Kotiloglu</given-names></name><aff>Consultant in Paediatric Pathology: Barts Health NHS Trust, London, UK.</aff></contrib></contrib-group><pub-date pub-type="ppub"><year>2018</year></pub-date><volume>31</volume><issue>101</issue><fpage>17</fpage><lpage>17</lpage><ext-link ext-link-type="uri" xlink:href="www.cehjournal.org"/><permissions><copyright-statement>Copyright &#x000a9; 2018 Caroline Thaung and Esin Kotiloglu Karaa.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/"><license-p>This is an Open Access article distributed under the Creative Commons Attribution Non-Commercial License.</license-p></license></permissions></article-meta></front><body><fig id="F1" position="anchor"><caption><p>Caroline Thaung</p></caption><graphic xlink:href="jceh_31_101_017_f01"/></fig><fig id="F2" position="anchor"><caption><p>Esin Kotiloglu Karaa</p></caption><graphic xlink:href="jceh_31_101_017_f02"/></fig><boxed-text position="float"><p><bold>Once an eye with retinoblastoma is excised, accurate histopathological staging is essential in order to determine whether the child can leave the hospital completely cured, or may need chemotherapy or radiotherapy.</bold></p></boxed-text><fig id="F3" position="anchor"><label>Figure 1</label><caption><p>If there is obvious extraocular extension such as an extrascleral nodule or orbital involvement in an exenteration specimen, the specimen should be sampled in such a way as to confirm this microscopically.</p></caption><graphic xlink:href="jceh_31_101_017_f03"/></fig><p>Surgical treatment for retinoblastoma is limited to enucleation (removal of the eye) or exenteration (removal of the eye and contents of the orbit). Histopathological examination of such specimens yields important information which must be taken into account when considering prognosis and making decisions about future management and treatment.</p><sec id="s1"><title>Standard histopathological reporting</title><p>When histopathologists are dealing with cancer specimens, their reports should include standard and appropriate information items, commonly known as a dataset. In the UK, histopathologists use datasets produced by the Royal College of Pathologists. Data items are reviewed every two years and aligned with the international tumour, node, metastasis, (TNM) classification. The TNM classification for retinoblastoma has recently been updated from TNM7 to TNM8. The newest dataset for retinoblastoma from the Royal College of Pathologists (RCPath), released in early 2018, reflects the changes in the TNM classification. Visit <bold><ext-link ext-link-type="uri" xlink:href="http://bit.ly/RBdataset">http://bit.ly/RBdataset</ext-link></bold></p><sec id="s2"><title>Histological high-risk features: rationale</title><p>The RCPath dataset for retinoblastoma records whether tumour is present in specific structures. Presence of tumour in any of these structures is considered a histological high-risk feature (HHRF). Retinoblastoma specimens with HHRFs indicate that the patient is at higher risk for metastasis (tumour spread) than a patient whose specimen does not have such features.</p><p>Detection of HHRFs by the histopathologist influences management decisions. The histopathologist examining the specimen should therefore specifically seek such features. The structures where tumour presence is regarded as an HHRF are:
<list list-type="bullet"><list-item><p>anterior chamber</p></list-item><list-item><p>iris</p></list-item><list-item><p>trabecular meshwork</p></list-item><list-item><p>Schlemm's canal</p></list-item><list-item><p>ciliary body</p></list-item><list-item><p>choroid (above a certain threshold)</p></list-item><list-item><p>sclera</p></list-item><list-item><p>extraocular structures</p></list-item><list-item><p>retrolaminar optic nerve (including the cut end).</p></list-item></list></p></sec><sec id="s3"><title>Gross examination of specimens</title><p>The RCPath dataset for retinoblastoma includes recommendations for macroscopic examination and sampling of globe and exenteration specimens. Even if resources are limited, it is useful to sample the cut end of the optic nerve separately (if length allows) as well as a &#x02018;PO block&#x02019; of the globe (see panel). If the globe is being opened fresh to sample tumour for cytogenetics, the optic nerve should be sampled first. This will avoid artefactual contamination.</p><p>The sampled optic nerve should be embedded transversely, so that a full cross-section can be evaluated. It can either be embedded on the true resection margin (surgeon's cut end) or the pathologist's cut end, as long as the orientation is known to the reporting pathologist.</p><p>For further information on what to look for microscopically (with figures), read this article on <bold><ext-link ext-link-type="uri" xlink:href="http://www.cehjournal.org">www.cehjournal.org</ext-link></bold>.</p><boxed-text id="box1" position="float"><caption><title>PO block</title></caption><p>This is a slice which includes the cornea, pupil and optic disc. It is typically obtained by making two parallel slices from anterior to posterior, one either side of the limbus. The orientation of the parallel slides may be sagittal, transverse or oblique, depending on the location of the tumour and any other pathology to be sampled.</p></boxed-text></sec></sec></body><back><ref-list><title>Further reading</title><ref id="B1"><mixed-citation publication-type="other"><bold><ext-link ext-link-type="uri" xlink:href="https://www.rcpath.org/profession/publications/cancer-datasets.html">https://www.rcpath.org/profession/publications/cancer-datasets.html</ext-link></bold> includes the current dataset for retinoblastoma and other tumours (free access).</mixed-citation></ref><ref id="B2"><mixed-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Brierley</surname><given-names>James</given-names></name><name><surname>Gospodarowicz</surname><given-names>M. K.</given-names></name><name><surname>Ch</surname><given-names>Wittekind</given-names></name></person-group>, eds. <article-title>TNM Classification of Malignant Tumours. Eighth edition.</article-title> Chichester, West Sussex, UK; <publisher-loc>Hoboken</publisher-loc>, NJ: <publisher-name>John Wiley &#x00026; Sons, Inc</publisher-name>, <year>2017</year></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>R. C</given-names></name></person-group> et al. <article-title>Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.</article-title>
<source>Br J Ophthalmol</source>
<volume>99</volume>, <fpage>1366</fpage>&#x02013;<lpage>1371</lpage> (<year>2015</year>) (free access)<pub-id pub-id-type="pmid">25873648</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sastre</surname><given-names>X</given-names></name></person-group> et al. <article-title>Proceedings of the Consensus Meetings From the Internationa Retinoblastoma Staging Working Group on the Pathology Guidelines for the Examination of Enucleated Eyes and Evaluation of Prognostic Risk Factors in Retinoblastoma.</article-title>
<source>Archives of Pathology &#x00026; Laboratory Medicine</source>
<volume>133</volume>, <fpage>1199</fpage>&#x02013;<lpage>1202</lpage> (<year>2009</year>) (free access)<pub-id pub-id-type="pmid">19653709</pub-id></mixed-citation></ref></ref-list></back></article>